Vanna Chiarion-Sileni, MD

Head of Melanoma & Esophageal Oncology Unit
Veneto Institute of Oncology IOV-IRCCS, Veneto, Italy, United States

Presentation(s):

• 63: Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)

  Friday, March 24, 2023
  11:24 AM – 11:34 AM

  Disclosure information not submitted.

• 54: Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Tumor Location in the Phase 3 KEYNOTE-716 Study

  Friday, March 24, 2023
  1:49 PM – 2:01 PM

  Disclosure information not submitted.